Ejim Mark is currently the Global Medical Unit Head for Autoimmune Diseases/Rheumatology at Takeda Pharmaceuticals in Cambridge, Massachusetts. He obtained his Medical Degree from Rostov Medical University and further specialized in primary and preventive care medicine at University of Kansas and Johns Hopkins University. Ejim also has an MBA from University of Massachusetts, Amherst.
Ejim has been working in drug development and medical affairs in immunology for over a decade.
Early bird registration is open and closes May 2025. Register now
